128 related articles for article (PubMed ID: 16320682)
1. [Incidence and predictors of thyroid dysfunction caused by long-term intake of amiodaron].
Serdiuk SE; Bakalov SA; Golitsyn SP; Molashenko NV; Platonova NM; Sviridenko NIu
Ter Arkh; 2005; 77(10):33-9. PubMed ID: 16320682
[TBL] [Abstract][Full Text] [Related]
2. [Cardiovascular manifestations of thyrotoxicosis and thyroid dysfunction caused by amiodarone].
Simkó J; Barta K; Szabó Z; Varga E; Nagy E; Lorincz I
Orv Hetil; 2004 Nov; 145(48):2411-7. PubMed ID: 15638034
[TBL] [Abstract][Full Text] [Related]
3. Amiodarone-induced thyroid dysfunction in cardiac patients from areas with iodine deficiency.
Trifănescu R; Fica S; Barbu C; Vârtej I; Ursu H; Bunghez R; Coculescu M
Rom J Intern Med; 2004; 42(3):595-605. PubMed ID: 16366133
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics of amiodarone-induced thyrotoxicosis and hypothyroidism in Japan.
Sato K; Miyakawa M; Eto M; Inaba T; Matsuda N; Shiga T; Ohnishi S; Kasanuki H
Endocr J; 1999 Jun; 46(3):443-51. PubMed ID: 10503998
[TBL] [Abstract][Full Text] [Related]
5. [Amiodarone-induced thyroid gland dysfunctions].
Gassanov N; Dietlein M; Caglayan E; Erdmann E; Er F
Dtsch Med Wochenschr; 2010 Apr; 135(16):807-11. PubMed ID: 20391312
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic particularities in amiodarone induced thyroid disorder in patients with underlying cardiac condition.
Costache L; Mogos V; Preda C; Vulpoi C; Ungureanu MC
Rev Med Chir Soc Med Nat Iasi; 2014; 118(4):959-64. PubMed ID: 25581954
[TBL] [Abstract][Full Text] [Related]
7. [Amiodarone and thyroid disorders--prospective study and review of the literature].
Vandergheynst F; Liénart F; Ducobu J
Rev Med Brux; 1999 Oct; 20(5):411-7. PubMed ID: 10582476
[TBL] [Abstract][Full Text] [Related]
8. Amiodarone-induced thyroid dysfunction in the Hong Kong Chinese population.
Lee KF; Lee KM; Fung TT
Hong Kong Med J; 2010 Dec; 16(6):434-9. PubMed ID: 21135419
[TBL] [Abstract][Full Text] [Related]
9. [Thyroid dysfunction in long-term amiodarone administration. Correlation of the antiarrhythmic activity of amiodarone with its effect on thyroid function].
Serdiuk SE; Bakalov SA; Golitsyn SP; Sitina VK; Molashenko NV; Platonova NM; Sviridenko NIu
Kardiologiia; 2005; 45(1):22-7. PubMed ID: 15699935
[TBL] [Abstract][Full Text] [Related]
10. Amiodarone-induced thyroid dysfunction.
Danzi S; Klein I
J Intensive Care Med; 2015 May; 30(4):179-85. PubMed ID: 24067547
[TBL] [Abstract][Full Text] [Related]
11. Determinants and outcome of amiodarone-associated thyroid dysfunction.
Ahmed S; Van Gelder IC; Wiesfeld AC; Van Veldhuisen DJ; Links TP
Clin Endocrinol (Oxf); 2011 Sep; 75(3):388-94. PubMed ID: 21535072
[TBL] [Abstract][Full Text] [Related]
12. [Clinical procedure in amiodarone-induced thyroid dysfunction].
Różycka-Kosmalska M; Michalak R; Kosmalski M; Ptaszyński P; Wranicz JK; Zieleniewski W; Cygankiewicz I
Pol Merkur Lekarski; 2016 Jan; 40(235):46-52. PubMed ID: 26891437
[TBL] [Abstract][Full Text] [Related]
13. Incidence and predictability of amiodarone-induced thyrotoxicosis and hypothyroidism.
Hofmann A; Nawara C; Ofluoglu S; Holzmannhofer J; Strohmer B; Pirich C
Wien Klin Wochenschr; 2008; 120(15-16):493-8. PubMed ID: 18820854
[TBL] [Abstract][Full Text] [Related]
14. Association between Serum Amiodarone and N-Desethylamiodarone Concentrations and Development of Thyroid Dysfunction.
Yamato M; Wada K; Hayashi T; Fujimoto M; Hosomi K; Oita A; Takada M
Clin Drug Investig; 2018 Jan; 38(1):39-48. PubMed ID: 29080209
[TBL] [Abstract][Full Text] [Related]
15. [The effects of amiodaron on the thyroid function].
Kucharczyk P; Michałkiewicz D; Kucharczyk A
Pol Merkur Lekarski; 2006 Jul; 21(121):86-9. PubMed ID: 17007301
[TBL] [Abstract][Full Text] [Related]
16. [Amiodarone-induced thyrotoxicosis: a diagnostic and therapeutic challenge].
Schuetz P; Eriksson U; Christ-Crain M; Zulewski H; Miller B
Praxis (Bern 1994); 2005 Sep; 94(36):1397-401. PubMed ID: 16190373
[TBL] [Abstract][Full Text] [Related]
17. Treatment of amiodarone-associated thyrotoxicosis.
Franklyn JA; Gammage MD
Nat Clin Pract Endocrinol Metab; 2007 Sep; 3(9):662-6. PubMed ID: 17710087
[TBL] [Abstract][Full Text] [Related]
18. [Amiodarone-associated thyroid dysfunction: prevalence and possibilities of correction].
Serdiuk SE; Bakalov SA; Soboleva VA; Golitsin SP; Molashenko NV; Platonova NM; Sviridenko NIu
Kardiologiia; 2004; 44(10):32-8. PubMed ID: 15477787
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoid response in amiodarone-induced thyrotoxicosis resulting from destructive thyroiditis is predicted by thyroid volume and serum free thyroid hormone concentrations.
Bogazzi F; Bartalena L; Tomisti L; Rossi G; Tanda ML; Dell'Unto E; Aghini-Lombardi F; Martino E
J Clin Endocrinol Metab; 2007 Feb; 92(2):556-62. PubMed ID: 17148557
[TBL] [Abstract][Full Text] [Related]
20. Amiodarone-induced thyroid dysfunction in an iodine-replete area: epidemiological and clinical data.
Zosin I; Balaş M
Endokrynol Pol; 2012; 63(1):2-9. PubMed ID: 22378090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
